Latest News and Press Releases

CALGARY, ALBERTA--(Marketwired - Jan. 25, 2017) - Drive Capital Corp. ("Drive Capital") an entity controlled by Jed M. Wood, acquired a CDN$1,000,000 convertible debenture (the...

BLACKFALDS, ALBERTA--(Marketwired - Jan. 25, 2017) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix"...

TORONTO, ONTARIO--(Marketwired - Jan. 6, 2017) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...

TORONTO, ONTARIO--(Marketwired - Jan. 5, 2017) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...

TORONTO, ONTARIO--(Marketwired - Dec. 22, 2016) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...

CALGARY, ALBERTA--(Marketwired - Nov. 2, 2016) - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS...

TORONTO, ONTARIO--(Marketwired - Oct. 3, 2016) - Hemostemix Inc. (the "Corporation") (TSX VENTURE:HEM)(OTCQB:HMTXF), a clinical-stage autologous cell-therapy company, announces that two...

TORONTO, ONTARIO--(Marketwired - Sept. 22, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM) (OTCQB:HMTXF) today announces a non-brokered private placement (the...

TORONTO, ONTARIO--(Marketwired - Sept. 21, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company) (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...

CALGARY, ALBERTA--(Marketwired - Sept. 9, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF) announces the results from its 2016 Annual and Special...